Teleflex has a Class I recall, Boston Scientific appoints two new board directors

28/06/2023 9 min
Teleflex has a Class I recall, Boston Scientific appoints two new board directors

Listen "Teleflex has a Class I recall, Boston Scientific appoints two new board directors"

Episode Synopsis

Sernova's positive interim data for the Cell Pouch System highlights the potential of regenerative medicine in addressing various medical conditions. Fast Five hosts Sean Whooley and Danielle Kirsh discuss the key findings in the data in today's episode.

Ultra-low frequency neuromodulation has the potential to revolutionize the field by offering more precise and targeted treatment options. Presidio Medical recently raised $72 million for its ultra-low frequency neuromodulation, and Whooley has all the details on the fundraising.

Augmedics' successful funding round and milestone of treating 4,000 U.S. patients with Xvision underscore the growing adoption and impact of augmented reality (AR) in surgical procedures. Hear how the Xvision technology works and why this was a significant capital raise.

Teleflex issued a Class I recall of its Arrow Endurance extended dwell peripheral catheter system. The Fast Five hosts provide more details about how many devices are affected and how many complaints there have been so far.

Boston Scientific elected Dr. Jessica Mega and Susan Morano to its board of directors. Whooley and Kirsh explore the appointees' career backgrounds and what CEO Mike Mahoney said about the appointments.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

More episodes of the podcast Fast Five Medtech News Podcast